non melanotic invasive skin cancer Non-melanoma Management of Non-melanoma Skin Cancers

Peptide therapy is not appropriate during pregnancy or breastfeeding, in active or recent cancer, in some autoimmune conditions, or for patients on certain medications

5-Amino-1MQ emerged from medicinal-chemistry programmes screening for selective NNMT inhibitors

Technically, these compounds do not bind mycotoxins but adsorb like static cling

The sublingual delivery route administers MT-II to the mucosa beneath the tongue, where the dense sublingual vasculature allows for systemic peptide absorption without the hepatic first-pass metabolism that limits oral bioavailability in most peptide formulations

It delivers regenerative exosomes through a fine mist that you inhale, allowing them to interact with your body's cells

Nat Genet 18:319324